Substantial progress has been made in developing effective diabetes prevention and care programs; however, significant gaps remain. A major gap is suboptimal uptake, adoption, and sustained use of evidence-based prevention and care programs, especially among minorities and underserved populations. To close this gap, there is a clear, cogent, and compelling public health priority to conduct methodologically rigorous and innovative diabetes translation research. Effective translation research can efficiently identify ways to improve uptake, adoption, utilization, and maintained engagement with evidence-based prevention and care programs. Core C (Engagement and Behavior Change) is well-positioned to catalyze this sort of diabetes translation research by leveraging its multidisciplinary expertise, its extensive experience in community- and clinic-based research, its access to ethnic minority physician practice networks, and its access to ethnic minority communities and clinical populations. The Core has extensive breadth and depth of experience and expertise in community-based participatory research (CBPR) with minority disadvantaged communities and clinical populations. Though these are often underrepresented populations in translation research, Core C brings experience in facilitating their ethical recruitment, retention, and sustained engagement in health promotion and research activities. Core Faculty also have extensive experience and expertise in the application of user- friendly mobile- and computer-based technologies to accelerate adoption and maintenance of health behaviors. The Core is also proficient in designing user-friendly technology for enhancing the quality, efficiency and cost-effective collection of participants' self-reported data. Core C will also partner with other Center Cores and Programs to implement a coordinated, innovative ?multidisciplinary team approach? to mentor early career investigators. To support researchers, the Core will develop specific products and services, such as User Guides (user-friendly and free PDFs and expert videos) to enhance understanding of the importance of CBPR principles and practices and to promote use of CBPR; assist in design and application of new technology to optimize translation research; and provide guidance on the applicability of technology to enhance the quality and efficiency of data collection. Core C will also provide direct consultation for investigators, in-person or via web-assisted video-based technology (this latter strategy is efficient and cost-effective in providing consultation to geographically disparate investigators). Core C will track utilization and impact of services via Google analytics for website-accessed products (type, number, and frequency of tools accessed and/or downloaded) and by requesting all Core users complete web-administered client satisfaction scales. This data will be used to monitor and improve the quality and usefulness of Core products and services. Core C's services may be instrumental in catalyzing research, particularly for minority populations, that will advance the field of diabetes translation research.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
1P30DK111024-01
Application #
9186837
Study Section
Special Emphasis Panel (ZDK1-GRB-1 (M2)P)
Project Start
Project End
Budget Start
2016-07-01
Budget End
2017-06-30
Support Year
1
Fiscal Year
2016
Total Cost
$71,113
Indirect Cost
$25,528
Name
Emory University
Department
Type
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Umpierrez, Guillermo E; Cardona, Saumeth; Chachkhiani, David et al. (2018) A Randomized Controlled Study Comparing a DPP4 Inhibitor (Linagliptin) and Basal Insulin (Glargine) in Patients With Type 2 Diabetes in Long-term Care and Skilled Nursing Facilities: Linagliptin-LTC Trial. J Am Med Dir Assoc 19:399-404.e3
Cha, EunSeok; Paul, Sudeshna; Braxter, Betty J et al. (2018) Dietary Behaviors and Glucose Metabolism in Young Adults at Risk for Type 2 Diabetes. Diabetes Educ 44:158-167
Umpierrez, Guillermo E; Klonoff, David C (2018) Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital. Diabetes Care 41:1579-1589
Gomez-Peralta, Fernando; Abreu, Cristina; Gomez-Rodriguez, Sara et al. (2018) Safety and Efficacy of DPP4 Inhibitor and Basal Insulin in Type 2 Diabetes: An Updated Review and Challenging Clinical Scenarios. Diabetes Ther 9:1775-1789
Vellanki, Priyathama; Umpierrez, Guillermo E (2018) Increasing Hospitalizations for DKA: A Need for Prevention Programs. Diabetes Care 41:1839-1841
Davis, Georgia; Fayfman, Maya; Reyes-Umpierrez, David et al. (2018) Stress hyperglycemia in general surgery: Why should we care? J Diabetes Complications 32:305-309
Ogilvie, Rachel P; Patel, Shivani A; Narayan, K M Venkat et al. (2018) Are the U.S. territories lagging behind in diabetes care practices? Prim Care Diabetes 12:432-437
Schultz, William M; Kelli, Heval M; Lisko, John C et al. (2018) Socioeconomic Status and Cardiovascular Outcomes: Challenges and Interventions. Circulation 137:2166-2178
Spanakis, Elias K; Levitt, David L; Siddiqui, Tariq et al. (2018) The Effect of Continuous Glucose Monitoring in Preventing Inpatient Hypoglycemia in General Wards: The Glucose Telemetry System. J Diabetes Sci Technol 12:20-25
Klonoff, David C; Umpierrez, Guillermo E; Rice, Mark J (2018) A Milestone in Point of Care Capillary Blood Glucose Monitoring of Critically Ill Hospitalized Patients. J Diabetes Sci Technol 12:1095-1100

Showing the most recent 10 out of 30 publications